- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Commercial Alliances Associate | New South Wales (NSW) | Australia | International | General Management | BD&L & Strategic Planning | Dec 02, 2025 |
| Business Data Migration Expert – Finance (Temporary 12 months) | INSURGENTES | Mexico | Operations | Strategic Planning & BD&L | BD&L & Strategic Planning | Dec 02, 2025 |
| Associate Director, Search & Evaluation | Cambridge (USA) | USA | Strategy & Growth | Strategic Planning & BD&L | BD&L & Strategic Planning | Dec 02, 2025 |
| Business Data Migration Expert - Manufacturing | Hyderabad (Office) | India | Operations | Strategic Planning & BD&L | BD&L & Strategic Planning | Dec 02, 2025 |
| Business Data Migration Expert-Sales Management | Hyderabad (Office) | India | Operations | Strategic Planning & BD&L | BD&L & Strategic Planning | Dec 02, 2025 |
| Business Data Migration Expert – Manufacturing | Hyderabad (Office) | India | Operations | Strategic Planning & BD&L | BD&L & Strategic Planning | Dec 02, 2025 |
| Associate Director- Lifecycle Management CoE | Dublin (NOCC) | Ireland | International | Marketing | BD&L & Strategic Planning | Dec 02, 2025 |
| Lead Consultant | East Hanover | USA | Finance | Finance | BD&L & Strategic Planning | Dec 02, 2025 |
| Strategic Assistant International Medical Affairs | Basel (City) | Switzerland | International | Marketing | BD&L & Strategic Planning | Nov 26, 2025 |
| Head of Search & Evaluation, Cardiovascular, Renal, & Metabolism | Cambridge (USA) | USA | Strategy & Growth | Strategic Planning & BD&L | BD&L & Strategic Planning | Oct 21, 2025 |
| LDC PMO – Consultant | Hyderabad (Office) | India | Operations | Strategic Planning & BD&L | BD&L & Strategic Planning | Aug 24, 2025 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى